FIBROBIOLOGICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.35 USD | -13.71% |
|
-25.49% | 0.00% |
| 06-13 | FibroBiologics to Join Russell 2000 Index in July | MT |
| 05-14 | FibroBiologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 175M 13.82B |
|---|---|---|---|---|---|
| Net income 2022 | -5M -395M | Net income 2023 | -16M -1.26B | EV / Sales 2022 * | - |
| Net cash position 2022 * | - 0 | Net cash position 2023 * | - 0 | EV / Sales 2023 * | - |
| P/E ratio 2022 * |
-
| P/E ratio 2023 * |
-
| Employees | 10 |
| Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 69.67% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -13.71% | ||
| 1 week | -25.49% | ||
| Current month | -56.08% | ||
| 1 month | -51.36% | ||
| 3 months | -57.10% |
1 week
5.30
7.57
1 month
5.3013.59
Current year
5.3055.00
1 year
5.3055.00
3 years
5.3055.00
5 years
5.3055.00
10 years
5.3055.00
| Managers | Title | Age | Since |
|---|---|---|---|
Peter O'Heeron
CEO | Chief Executive Officer | 61 | 07/04/21 |
Mark Andersen
DFI | Director of Finance/CFO | 53 | 31/05/22 |
Hamid Khoja
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/07/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Hoffman
BRD | Director/Board Member | 58 | 07/04/21 |
| Director/Board Member | 61 | 07/04/21 | |
Peter O'Heeron
CEO | Chief Executive Officer | 61 | 07/04/21 |
FibroBiologics Inc is a United States-based company. The Company operates as a biopharmaceutical company. It is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. It also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.
Calendar
27/08/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 175M | |
| +15.85% | 122B | |
| +18.91% | 113B | |
| +4.43% | 22.84B | |
| -18.63% | 20.72B | |
| -13.76% | 16.39B | |
| -16.61% | 16.51B | |
| -43.53% | 15.83B | |
| +1.75% | 13.49B | |
| +28.07% | 11.67B |
- Stock Market
- Equities
- FBLG Stock
